In human osteosarcoma, elevated expression levels of macrophage and CD4 T-cell markers (defined as CD4/IFNGR2/CD68/CSF1R signature) was associated with favorable neoadjuvant chemotherapy responses (40). This evidence concerns the gene CD4 and osteosarcoma.